These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12774314)

  • 1. Effect of tranexamic acid incorporated in fibrin sealant clots on the cell behavior of neuronal and nonneuronal cells.
    Cox S; Cole M; Mankarious S; Tawil N
    J Neurosci Res; 2003 Jun; 72(6):734-46. PubMed ID: 12774314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
    Saed GM; Kruger M; Diamond MP
    Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.
    Buchta C; Hedrich HC; Macher M; Höcker P; Redl H
    Biomaterials; 2005 Nov; 26(31):6233-41. PubMed ID: 15921738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell compatibility of fibrin sealants: in vitro study with cells involved in soft tissue repair.
    Macasev D; Diorio JP; Gugerell A; Goppelt A; Gulle H; Bittner M
    J Biomater Appl; 2011 Aug; 26(2):129-49. PubMed ID: 20624847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fibrin sealant composition on human neutrophil chemotaxis.
    Hanson AJ; Quinn MT
    J Biomed Mater Res; 2002 Sep; 61(3):474-81. PubMed ID: 12115473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human U937 monocyte behavior and protein expression on various formulations of three-dimensional fibrin clots.
    Mana M; Cole M; Cox S; Tawil B
    Wound Repair Regen; 2006; 14(1):72-80. PubMed ID: 16476075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Diamond MP; Kruger M; Saed GM
    Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
    Stendel R; Scheurer L; Schlatterer K; Gminski R; Möhler H
    Anticancer Res; 2004; 24(2B):631-8. PubMed ID: 15161005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant.
    Jegoux F; Goyenvalle E; Bagot D'arc M; Aguado E; Daculsi G
    Arch Orthop Trauma Surg; 2005 Apr; 125(3):153-9. PubMed ID: 15761734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific fibrinogen and thrombin concentrations promote neuronal rather than glial growth when primary neural cells are seeded within plasma-derived fibrin gels.
    Mooney R; Tawil B; Mahoney M
    Tissue Eng Part A; 2010 May; 16(5):1607-19. PubMed ID: 20028220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration.
    Cox S; Cole M; Tawil B
    Tissue Eng; 2004; 10(5-6):942-54. PubMed ID: 15265312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model.
    Schlag MG; Hopf R; Redl H
    Neurosurgery; 2000 Dec; 47(6):1463-7. PubMed ID: 11126922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin sealants in clinical practice.
    Albala DM
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():5-11. PubMed ID: 12869982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High thrombin concentrations in fibrin sealants induce apoptosis in human keratinocytes.
    Gugerell A; Schossleitner K; Wolbank S; Nürnberger S; Redl H; Gulle H; Goppelt A; Bittner M; Pasteiner W
    J Biomed Mater Res A; 2012 May; 100(5):1239-47. PubMed ID: 22359340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of different fibrin sealants on fibroblast activity in skin wounds. Experimental studies in rats].
    Nagelschmidt M; Röddecker K; Gierse T; Troidl H
    Arzneimittelforschung; 1990 Oct; 40(10):1166-71. PubMed ID: 2291757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New method to prepare autologous fibrin glue on demand.
    Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
    Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of modified polysialic acid based hydrogels on the adhesion and viability of primary neurons and glial cells.
    Haile Y; Berski S; Dräger G; Nobre A; Stummeyer K; Gerardy-Schahn R; Grothe C
    Biomaterials; 2008 Apr; 29(12):1880-91. PubMed ID: 18255143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological in vitro effects of fibrin glue: fibroblast proliferation, expression and binding of growth factors.
    Becker JC; Domschke W; Pohle T
    Scand J Gastroenterol; 2004 Oct; 39(10):927-32. PubMed ID: 15513329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid--an alternative to aprotinin in fibrin-based cardiovascular tissue engineering.
    Cholewinski E; Dietrich M; Flanagan TC; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part A; 2009 Nov; 15(11):3645-53. PubMed ID: 19496679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.